The Effect of Mandala on Anxiety, Physiological Parameters and Patient Satisfaction in Women With Breast Cancer
1 other identifier
interventional
54
1 country
1
Brief Summary
This study will be conducted to examine the effect of mandala painting on anxiety, physiological parameters and patient satisfaction in women with breast cancer receiving chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Feb 2024
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 24, 2024
CompletedFirst Submitted
Initial submission to the registry
December 6, 2024
CompletedFirst Posted
Study publicly available on registry
December 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedJuly 3, 2025
June 1, 2025
1.3 years
December 6, 2024
June 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Physiological parameter 1
Temperature
2 hours (pre-test and post-test)
Physiological parameter 2
Pulse
2 hours (pre-test and post-test)
Physiological parameter 3
Blood pressure
2 hours (pre-test and post-test)
Physiological parameter 4
spO2
2 hours (pre-test and post-test)
Physiological parameter 5
Respiratory rate
2 hours (pre-test and post-test)
Secondary Outcomes (1)
Beck Anxiety Scale
2 hours (pre-test and post-test)
Study Arms (2)
Mandala Group
EXPERIMENTALThe patient will undergo mandala painting during 1 session of chemotherapy.
Control Group
NO INTERVENTIONNo application will be made to this group by the researcher.
Interventions
The patient will undergo mandala painting during 1 session of chemotherapy.
Eligibility Criteria
You may qualify if:
- Being diagnosed with breast cancer,
- Being receiving adjuvant or neoadjuvant chemotherapy,
- Being over 18 years of age,
- Ability to communicate in Turkish,
- Not having a physical disability related to the upper extremities,
- Agreeing to participate in the study.
You may not qualify if:
- Advanced stage cancer patients,
- Having visual, hearing and speech disabilities,
- Individuals with mental and neuropsychiatric diseases will not be included in the sample.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sağlık Bilimleri Üniversitesi
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Filiz Ünal Toprak
Saglik Bilimleri Universitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Since the application will be performed by the researcher, patients will be blinded in this study. The statistician will be blinded in the evaluation of the data.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. Dr.
Study Record Dates
First Submitted
December 6, 2024
First Posted
December 16, 2024
Study Start
February 24, 2024
Primary Completion
May 30, 2025
Study Completion
June 30, 2025
Last Updated
July 3, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share